2 results
Approved WMOCompleted
This study is aimed to determine the efficacy of varenicline in reducing EDS in PD patients.
Approved WMOCompleted
The objectives of this study are to compare the safety and efficacy of 2 annual cycles of intravenous (IV) alemtuzumab to 3-times weekly subcutaneous (SC) interferon beta 1a (Rebif*) in patients with active relapsing-remitting multiple sclerosis (…